TRIM16 is an E3 ubiquitin ligase that functions as a critical regulator of autophagy, oxidative stress responses, and cellular homeostasis across multiple tissues. The protein facilitates secretory autophagy by trafficking to autophagosomes and mediating the transport of cargo, including IL6, to the plasma membrane for secretion 1. TRIM16 protects against oxidative stress through multiple mechanisms: it enhances SIRT-1-dependent antioxidant responses to mitigate age-related sarcopenia 2, suppresses cardiac hypertrophy by preventing Prdx1 phosphorylation and enhancing Nrf2 signaling 3, and promotes osteogenic differentiation by stabilizing ULK1 and Beclin1 to enhance autophagy 4. The protein also regulates pathological processes through K63-linked ubiquitination of target proteins, such as DAB2 in vascular calcification 5 and phospho-TAK1 degradation in nonalcoholic steatohepatitis 6. Clinically, TRIM16 shows promise as a therapeutic target, with its expression correlating with disease severity in cardiac hypertrophy and its modulation affecting progression of vascular calcification, liver steatohepatitis, and age-related muscle atrophy. The protein's dual roles in autophagy regulation and oxidative stress protection make it a key player in cellular adaptation to metabolic and environmental stress.